von Willebrand factor (VWF) is a multimeric protein consisting of covalently linked monomers, which share an identical domain architecture. Although involved in processes such as inflammation, angiogenesis, and cancer metastasis, VWF is mostly known for its role in hemostasis, by acting as a chaperone protein for coagulation factor VIII (FVIII) and by contributing to the recruitment of platelets during thrombus formation. To serve its role in hemostasis, VWF needs to bind a variety of ligands, including FVIII, platelet-receptor glycoprotein Ib-α, VWF-cleaving protease ADAMTS13, subendothelial collagen, and integrin α-IIb/β-3. Importantly, interactions are differently regulated for each of these ligands. How are these binding events accomplished and coordinated? The basic structures of the domains that constitute the VWF protein are found in hundreds of other proteins of prokaryotic and eukaryotic organisms. However, the determination of the 3-dimensional structures of these domains within the VWF context and especially in complex with its ligands reveals that exclusive, VWF-specific structural adaptations have been incorporated in its domains. They provide an explanation of how VWF binds its ligands in a synchronized and timely fashion. In this review, we have focused on the domains that interact with the main ligands of VWF and discuss how elucidating the 3-dimensional structures of these domains has contributed to our understanding of how VWF function is controlled. We further detail how mutations in these domains that are associated with von Willebrand disease modulate the interaction between VWF and its ligands.
Skip Nav Destination
VON WILLEBRAND FACTOR, FACTOR VIII, AND FACTOR IX|
November 21, 2024
How unique structural adaptations support and coordinate the complex function of von Willebrand factor
Peter J. Lenting,
Peter J. Lenting
Université Paris-Saclay, INSERM, Hémostase Inflammation Thrombose HITh U1176, Le Kremlin-Bicêtre, France
Search for other works by this author on:
Cécile V. Denis,
Cécile V. Denis
Université Paris-Saclay, INSERM, Hémostase Inflammation Thrombose HITh U1176, Le Kremlin-Bicêtre, France
Search for other works by this author on:
Olivier D. Christophe
Olivier D. Christophe
Université Paris-Saclay, INSERM, Hémostase Inflammation Thrombose HITh U1176, Le Kremlin-Bicêtre, France
Search for other works by this author on:
Blood (2024) 144 (21): 2174–2184.
Article history
Submitted:
March 7, 2024
Accepted:
June 17, 2024
First Edition:
July 5, 2024
Connected Content
A related article has been published:
Blood coagulation factor IX: structural insights impacting hemophilia B therapy
A related article has been published:
Coagulation factor VIII: biological basis of emerging hemophilia A therapies
A related article has been published:
Introduction to a review series on von Willebrand factor, factor VIII, and factor IX
Citation
Peter J. Lenting, Cécile V. Denis, Olivier D. Christophe; How unique structural adaptations support and coordinate the complex function of von Willebrand factor. Blood 2024; 144 (21): 2174–2184. doi: https://doi.org/10.1182/blood.2023023277
Download citation file:
My Account
Sign In
November 21 2024
Advertisement intended for health care professionals
2
Crossref
Cited By
Advertisement intended for health care professionals
This feature is available to Subscribers Only
Sign In or Create an Account Close Modal